Can magnesium sulfate prophylaxis reduce colistin nephrotoxicity?

Area of Science:

• Nephrology
• Pharmacology
• Toxicology

Background:

• Colistin is an antibiotic with known nephrotoxicity.
• Magnesium sulfate is used in various medical treatments.
• The protective effect of magnesium sulfate against colistin nephrotoxicity is not well-established.

Purpose of the Study:

• To investigate the potential nephroprotective role of magnesium sulfate against colistin-induced kidney damage in a rat model.

Main Methods:

• Wistar Albino rats were divided into control, colistin, magnesium sulfate, and magnesium sulfate + colistin groups.
• Kidney function was assessed by measuring urea and creatinine levels.
• Oxidative stress markers (malondialdehyde and glutathione) were analyzed.
• Kidney tissue damage was evaluated using histopathological examination and a semiquantitative scoring system.

Main Results:

• Colistin administration significantly increased urea and creatinine levels, indicating nephrotoxicity.
• Magnesium sulfate administration, alone and with colistin, resulted in significantly lower urea and creatinine levels compared to the colistin-only group.
• Colistin treatment led to increased plasma and kidney malondialdehyde levels and significant kidney tissue damage.
• The magnesium sulfate + colistin group showed reduced renal malondialdehyde levels and less severe histopathological damage compared to the colistin group.

Conclusions:

• Magnesium sulfate demonstrates a nephroprotective effect against colistin-induced kidney injury.
• Magnesium sulfate may mitigate colistin nephrotoxicity by reducing oxidative stress and histopathological damage.